Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > VEGF-C

VEGF-C

Brief Information

Name:Vascular endothelial growth factor C
Target Synonym:LMPHM4,Vascular Endothelial Growth Factor-Related Protein,Flt4-L,VRP,FLT4 Ligand DHM,LMPH1D,VEGF-C,Vascular Endothelial Growth Factor C,Flt4 ligand,VEGFC
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
VEC-M82E3 Mouse Biotinylated Mouse VEGF-C Protein, His,Avitag™ (MALS verified)
VEC-M82E3-structure
VEC-M82E3-sds
VEC-C82E4 Cynomolgus Biotinylated Cynomolgus VEGF-C Protein, His,Avitag™ (MALS verified)
VEC-C82E4-structure
VEC-C82E4-sds
VEC-H52H3 Human Human VEGF-C / Flt4-L Protein, His Tag (MALS verified)
VEC-H52H3-structure
VEC-H52H3-sds
ACRO Quality

Part of Bioactivity data

VEC-H52H3-SPR
VEGF-C SPR

Human VEGF-C Protein, His Tag (Cat. No. VEC-H52H3) capture on NTA-Series S sensor chip can bind  Human VEGF R3, Fc Tag (Cat. No. FL4-H5251) with an affinity constant of 0.130 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Protocol
VEC-C82E4-ELISA
VEGF-C ELISA

Immobilized Human VEGF R2, Fc Tag (Cat. No. VE2-H5255) at 5 μg/mL (100 μL/well) can bind Biotinylated Cynomolgus VEGF-C Protein, His,Avitag (Cat. No. VEC-C82E4) with a linear range of 0.2-5 ng/mL (QC tested).

Protocol

Synonym Name

VEGFC,Flt4-L,VRP

Background

Vascular endothelial growth factor C is also known as VEGFC, Flt4-L and VRP, it contains the C-terminal propeptide which has an unusual structure with tandemly repeated cysteine-rich motifs. Upon biosynthesis, VEGFC is secreted as a non-covalent momodimer in an anti-parellel fashion. VEGFC is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family, is active in angiogenesis, lymphangiogenesis and endothelial cell growth and survival, and can also affect the permeability of blood vessels. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms that bind and activate VEGFR-3 receptors. Only the fully processed form can bind and activate VEGFR-2 receptors. The structure and function of this protein is similar to those of vascular endothelial growth factor D (VEGF-D). VEGFC may function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Overexpression of VEGF-C causes lymphatics to enlarge possibly facilitates metastasis.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Sozinibercept OPT-302; VGX-300 Phase 3 Clinical Orphan Europe Sarl Neovascularization, Pathologic; Retinal Diseases; Diabetic macular oedema; Retinal Degeneration; Eye Diseases; Macular Degeneration Details
VEGF-C gene therapy (Herantis Pharma) LX-1101; Ad-VEGF-C Phase 2 Clinical Herantis Pharma Lymphedema Details
IBI-333 IBI-333 Phase 1 Clinical Innovent Biologics (Usa), Inc Wet Macular Degeneration; Macular Degeneration Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap